Search Videos and More
News
Upending NSCLC Survival Rates with New Care Paradigms
For years, researcher-clinician Hossein Borghaei, DO, MS, Chief, Thoracic Medical Oncology, Fox Chase Cancer Center, has been at the forefront of global exploration into the genetic, proteomics, and cellular landscape of non-small cell lung cancer (NSCLC). These efforts have led to the development of innovative clinical trials and new therapeutic paradigms.
News
Fox Chase Cancer Center and Temple Health Physicians and Scientists Present Research at the American Society of Hematology 2024 Annual Meeting
Fox Chase Cancer Center and Temple Health physicians and scientists participated in the presentation and discussion of eight research projects at the American Society of Hematology (ASH) 2024 Annual Meeting, held this past December in San Diego.
News
We All Rise Together: Dr. Camille Ragin's Vision for Health Equity in Cancer Care
The statistics are riveting: Throughout the world, approximately 17 percent of the human population are individuals of African descent.
News
National and International Accolades
Meet the bold clinicians and researchers whose work and perseverance push the edge of discovery, and have helped Fox Chase Cancer Center reach our 50th anniversary of excellence in cancer care.
News
From ZIP Code to Genomic Code: First Miami, Now NYC, and Finally, the USA.
Years before Neha Goel, MD, MPH, FACS, became a Fox Chase Cancer Center Fellow in Complex Surgical Oncology, the direction of her life’s work was being shaped.
News
“You must be willing to live and breathe breast cancer.”
Richard Bleicher, MD, FACS, recently appointed Chief of the new Division of Breast Surgery, and a long-term director of the Fox Chase Cancer Center Breast Oncology Fellowship, describes the rigorous training and dedication expected of a Fox Chase Breast Oncology Fellow.
Document
The Multidisciplinary Approach at Fox Chase Cancer Center
Where your patient starts their cancer journey matters. Behind every patient at Fox Chase Cancer Center is a multidisciplinary team of highly experienced and trained specialists who provide compassionate care and ensure the best possible outcomes with the
News
Like Mother, Like Son
A mother and son’s talents and a duo of DAISY awards.
News
Fox Chase Cancer Center’s Dr. Thomas J. Galloway Named a Fellow of the American Society for Radiation Oncology
Thomas J. Galloway, MD, Chief of the Division of Head and Neck Radiation Oncology at Fox Chase Cancer Center, was today named a Fellow of the American Society for Radiation Oncology (ASTRO) at its 66th Annual Meeting in Washington, D.C.
News
Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Effectively Delivers Treatment for Liver Tumors in Study Presented at American Society for Radiation Oncology Meeting
Using CT-guided online adaptive radiation therapy (ART) for patients with liver tumors has proven to be an effective approach, according to findings presented today by Fox Chase Cancer Center researchers at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Washington, D.C.
News
Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University’s Dr. Eric Horwitz Elected to Executive Committee of Radiation Oncology Society
Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University, was elected to the Executive Committee of the Society of Chairs of Academic Radiation Oncology Programs (SCAROP), part of the American Society of Radiation Oncology (ASTRO).
News
Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Delivers Treatment More Effectively in Study Presented at American Society for Radiation Oncology Meeting
Online adaptive radiation therapy (ART) delivered radiation more effectively than conventional radiation therapy in nearly half of patients, while also helping to decrease radiation dose to the esophagus in a majority of patients with thoracic spine tumors. That’s according to the results of a study presented today by Fox Chase Cancer Center researchers at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Washington, D.C.